-
Posting Date: 11/11/2021
EDI E-mail Inquiry Form Bottom
Once you submit your completed form, you should receive an automated acknowledgement stating your email inquiry has been received by EDI. Response time for email inquiries is within ten business days of receipt. Please make sure you [...]
Read More -
Posting Date: 11/15/2021
Part B Remittance Statements Missing Financial Control Numbers
Due to an issue associated with the 10/1/2021 release, Part B remittances classified as withholding (WO) are being generated without FCN information. Without the necessary control number, providers cannot cross-reference the reason for [...]
Read More -
Posting Date: 05/05/2021
Check Provider Enrollment Application Status
This inquiry tool can be used to check on the status of your application. How to Search To perform a search please enter into a field below either a valid Case Number/Web Tracking ID (Option 1) or a valid National Provider [...]
Read More -
Posting Date: 11/16/2021
Technical Guides and Information
Technical Guides and Information 5010 Process Flow Chart X12 Website: Technical Reports/Implementation Guides, Newsletters and X12 Transaction Sets
Read More -
Posting Date: 11/19/2021
Accessing the Inquiries Submenu
Chapter IV: Inquiries Submenu (01) Accessing the Inquiries Submenu Purpose This section explains how to access the Inquiries submenu from the Main Menu. Task To access the Inquiries submenu from the FISS/DDE Provider Online System Main [...]
Read More -
Posting Date: 04/14/2021
MLN Connects® Special Edition for Wednesday, April 14, 2021
MLN Connects® Special Edition for Wednesday, April 14, 2021 J&J COVID-19 Vaccine: Health Alert The CDC issued a Health Alert, about the CDC and FDA’s recommended pause in the use of the J&J COVID-19 vaccine, in part, to ensure that [...]
Read More -
Posting Date: 04/20/2021
MLN Connects® Special Edition for Tuesday, April 20, 2021
MLN Connects® Special Edition for Tuesday, April 20, 2021 COVID-19 Update: FDA Revoked the EUA for Bamlanivimab When Administered Alone On April 16, the FDA revoked the Emergency Use Authorization (EUA) for bamlanivimab, when administered [...]
Read More